Lemur catta isolate mLemCat1 chromosome 26, mLemCat1.pri, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Euarchontoglires; Primates; Strepsirrhini; Lemuriformes; Lemuridae; Lemur.
REFSEQ INFORMATION: The reference sequence is identical to\nCM036497.1.\nAssembly name: mLemCat1.pri\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Vertebrate Genomes Project on\n2021/11/04. The original whole-genome shotgun project has the\naccession JAJGPY000000000.1.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Vertebrate Genomes Project\nAssembly Date :: 16-JUL-2021\nAssembly Method :: hifiasm v. 0.12-r304; purge_dups v.\n 1.2.5; bionano_solve v.\n Solve3.6.1_11162020; salsa2 v. v2.2;\n gEVAL manual curation v. 2021-07-16\nAssembly Name :: mLemCat1.pri\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 20.81x\nSequencing Technology :: Pacbio Sequel II CCS; 10X Genomics linked\n reads; Bionano Genomics DLS; Arima\n Genomics v1 Hi-C\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Lemur catta Annotation Release 100\nAnnotation Version :: 100\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
centromere protein E, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
centromere protein E, transcript variant X4
centromere protein E, transcript variant X2
centromere protein E, transcript variant X5
centromere protein E, transcript variant X3
centromere-associated protein E isoform X4
centromere-associated protein E isoform X2
centromere-associated protein E isoform X5
centromere-associated protein E isoform X3
centromere-associated protein E isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 ESTs, 4 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123627653, transcript variant X1
uncharacterized LOC123627653, transcript variant X2
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
tet methylcytosine dioxygenase 2, transcript variant X1
tet methylcytosine dioxygenase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
tet methylcytosine dioxygenase 2, transcript variant X2
methylcytosine dioxygenase TET2 isoform X1
methylcytosine dioxygenase TET2 isoform X2
inorganic pyrophosphatase 2, transcript variant X1
inorganic pyrophosphatase 2, transcript variant X2
inorganic pyrophosphatase 2, mitochondrial isoform X2
inorganic pyrophosphatase 2, mitochondrial isoform X1
Rho guanine nucleotide exchange factor 38
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments
integrator complex subunit 12, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 72 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
integrator complex subunit 12, transcript variant X5
integrator complex subunit 12, transcript variant X6
integrator complex subunit 12, transcript variant X3
integrator complex subunit 12, transcript variant X4
integrator complex subunit 12, transcript variant X2
integrator complex subunit 12, transcript variant X1
glutathione S-transferase C-terminal domain containing, transcript variant X1
glutathione S-transferase C-terminal domain containing, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
glutathione S-transferase C-terminal domain containing, transcript variant X2
glutathione S-transferase C-terminal domain containing, transcript variant X3
glutathione S-transferase C-terminal domain-containing protein isoform X1
glutathione S-transferase C-terminal domain-containing protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TBC1 domain containing kinase, transcript variant X2
TBC1 domain containing kinase, transcript variant X4
TBC1 domain containing kinase, transcript variant X7
TBC1 domain containing kinase, transcript variant X1
TBC1 domain containing kinase, transcript variant X5
TBC1 domain containing kinase, transcript variant X3
TBC domain-containing protein kinase-like protein isoform X3
TBC domain-containing protein kinase-like protein isoform X1
TBC1 domain containing kinase, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 56 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TBC domain-containing protein kinase-like protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aminoacyl tRNA synthetase complex interacting multifunctional protein 1
aminoacyl tRNA synthase complex-interacting multifunctional protein 1
uncharacterized LOC123627727, transcript variant X1
GIMAP family P-loop NTPase domain containing 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 2 bases in 2 codons; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: GTPase IMAP family member GIMD1
uncharacterized LOC123627727, transcript variant X2
dickkopf WNT signaling pathway inhibitor 2
COORDINATES: nucleotide motif:Rfam:12.0:RF00020
uncharacterized LOC123627729, transcript variant X2
uncharacterized LOC123627729, transcript variant X1
3'-phosphoadenosine 5'-phosphosulfate synthase 1, transcript variant X4
3'-phosphoadenosine 5'-phosphosulfate synthase 1, transcript variant X5
3'-phosphoadenosine 5'-phosphosulfate synthase 1, transcript variant X2
3'-phosphoadenosine 5'-phosphosulfate synthase 1, transcript variant X3
3'-phosphoadenosine 5'-phosphosulfate synthase 1, transcript variant X1
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 isoform X2
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 isoform X3
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 isoform X1
bifunctional 3'-phosphoadenosine 5'-phosphosulfate synthase 1 isoform X4
sphingomyelin synthase 2, transcript variant X6
sphingomyelin synthase 2, transcript variant X5
sphingomyelin synthase 2, transcript variant X1
sphingomyelin synthase 2, transcript variant X2
sphingomyelin synthase 2, transcript variant X4
sphingomyelin synthase 2, transcript variant X3
sphingomyelin synthase 2, transcript variant X7
sphingomyelin synthase 2, transcript variant X8
phosphatidylcholine:ceramide cholinephosphotransferase 2
cytochrome P450 2U1, transcript variant X1
cytochrome P450 2U1, transcript variant X2
cytochrome P450 2U1, transcript variant X4
cytochrome P450 2U1, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cytochrome P450 2U1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytochrome P450 2U1, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 1 Protein, and 88% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cytochrome P450 2U1, transcript variant X7
cytochrome P450 2U1, transcript variant X3
hydroxyacyl-CoA dehydrogenase, transcript variant X2
hydroxyacyl-CoA dehydrogenase, transcript variant X1
hydroxyacyl-coenzyme A dehydrogenase, mitochondrial
lymphoid enhancer binding factor 1, transcript variant X4
lymphoid enhancer binding factor 1, transcript variant X3
lymphoid enhancer binding factor 1, transcript variant X2
lymphoid enhancer binding factor 1, transcript variant X1
lymphoid enhancer-binding factor 1 isoform X3
lymphoid enhancer-binding factor 1 isoform X1
lymphoid enhancer-binding factor 1 isoform X4
lymphoid enhancer-binding factor 1 isoform X2
ribosomal protein L34, transcript variant X1
ribosomal protein L34, transcript variant X2
ribosomal protein L34, transcript variant X3
oligosaccharyltransferase complex non-catalytic subunit
oligosaccharyltransferase complex subunit OSTC
collagen type XXV alpha 1 chain, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 18% coverage of the annotated genomic feature by RNAseq alignments
collagen type XXV alpha 1 chain, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
ethanolamine-phosphate phospho-lyase, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 52 ESTs, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ethanolamine-phosphate phospho-lyase, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ethanolamine-phosphate phospho-lyase isoform X1
ethanolamine-phosphate phospho-lyase isoform X2
ethanolamine-phosphate phospho-lyase, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ethanolamine-phosphate phospho-lyase isoform X3
ethanolamine-phosphate phospho-lyase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ethanolamine-phosphate phospho-lyase isoform X4
SEC24 homolog B, COPII coat complex component, transcript variant X1
SEC24 homolog B, COPII coat complex component, transcript variant X2
SEC24 homolog B, COPII coat complex component, transcript variant X3
SEC24 homolog B, COPII coat complex component, transcript variant X4
protein transport protein Sec24B isoform X1
protein transport protein Sec24B isoform X2
protein transport protein Sec24B isoform X3
protein transport protein Sec24B isoform X4
SEC24 homolog B, COPII coat complex component, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 63 ESTs, 1 Protein, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
SEC24 homolog B, COPII coat complex component, transcript variant X6
protein transport protein Sec24B isoform X5
mitochondrial calcium uniporter dominant negative subunit beta
calcium uniporter regulatory subunit MCUb, mitochondrial
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123627751, transcript variant X2
uncharacterized LOC123627751, transcript variant X1
retinal pigment epithelium-derived rhodopsin homolog, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 ESTs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
retinal pigment epithelium-derived rhodopsin homolog, transcript variant X2
visual pigment-like receptor peropsin isoform X1
visual pigment-like receptor peropsin isoform X2
retinal pigment epithelium-derived rhodopsin homolog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
visual pigment-like receptor peropsin isoform X3
leucine rich repeat, Ig-like and transmembrane domains 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
leucine-rich repeat, immunoglobulin-like domain and transmembrane domain-containing protein 3
epidermal growth factor, transcript variant X1
epidermal growth factor, transcript variant X2
ELOVL fatty acid elongase 6, transcript variant X3
ELOVL fatty acid elongase 6, transcript variant X2
ELOVL fatty acid elongase 6, transcript variant X1
elongation of very long chain fatty acids protein 6
paired like homeodomain 2, transcript variant X3
paired like homeodomain 2, transcript variant X2
paired like homeodomain 2, transcript variant X1
family with sequence similarity 241 member A
adaptor related protein complex 1 associated regulatory protein
AP-1 complex-associated regulatory protein
TRAF interacting protein with forkhead associated domain
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
TRAF-interacting protein with FHA domain-containing protein A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 52 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
La ribonucleoprotein 7, transcriptional regulator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97 ESTs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
La ribonucleoprotein 7, transcriptional regulator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 97 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 ESTs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
calcium/calmodulin dependent protein kinase II delta, transcript variant X6
calcium/calmodulin dependent protein kinase II delta, transcript variant X7
calcium/calmodulin dependent protein kinase II delta, transcript variant X4
calcium/calmodulin dependent protein kinase II delta, transcript variant X2
calcium/calmodulin dependent protein kinase II delta, transcript variant X3
calcium/calmodulin dependent protein kinase II delta, transcript variant X5
calcium/calmodulin dependent protein kinase II delta, transcript variant X1
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X6
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X5
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X7
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X4
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X2
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X3
calcium/calmodulin-dependent protein kinase type II subunit delta isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 95 ESTs, 2 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
COORDINATES: nucleotide motif:Rfam:12.0:RF00004
2-hydroxyacylsphingosine 1-beta-galactosyltransferase
N-deacetylase and N-sulfotransferase 4, transcript variant X1
N-deacetylase and N-sulfotransferase 4, transcript variant X2
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 isoform X2
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 4 isoform X1
translocation associated membrane protein 1 like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
translocating chain-associated membrane protein 1-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 18 ESTs, 29 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3
uncharacterized LOC123627693, transcript variant X5
uncharacterized LOC123627693, transcript variant X3
uncharacterized LOC123627693, transcript variant X2
uncharacterized LOC123627693, transcript variant X4
uncharacterized LOC123627693, transcript variant X1
COORDINATES: nucleotide motif:Rfam:12.0:RF00399
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 ESTs, 14 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
methyltransferase 14, N6-adenosine-methyltransferase subunit, transcript variant X1
N6-adenosine-methyltransferase non-catalytic subunit isoform X1
methyltransferase 14, N6-adenosine-methyltransferase subunit, transcript variant X2
N6-adenosine-methyltransferase non-catalytic subunit isoform X2
methyltransferase 14, N6-adenosine-methyltransferase subunit, transcript variant X3
N6-adenosine-methyltransferase non-catalytic subunit isoform X3
SEC24 homolog D, COPII coat complex component
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 ESTs, 9 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
ubiquitin specific peptidase 53, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 ESTs, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
ubiquitin specific peptidase 53, transcript variant X1
ubiquitin specific peptidase 53, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 ESTs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inactive ubiquitin carboxyl-terminal hydrolase 53 isoform X1
inactive ubiquitin carboxyl-terminal hydrolase 53 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
phosphodiesterase 5A, transcript variant X2
phosphodiesterase 5A, transcript variant X1
cGMP-specific 3',5'-cyclic phosphodiesterase isoform X2
cGMP-specific 3',5'-cyclic phosphodiesterase isoform X1
uncharacterized LOC123627667, transcript variant X1
uncharacterized LOC123627667, transcript variant X2
mitotic spindle assembly checkpoint protein MAD2A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 ESTs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
neuron derived neurotrophic factor, transcript variant X2
neuron derived neurotrophic factor, transcript variant X1
neuron derived neurotrophic factor, transcript variant X3
neuron derived neurotrophic factor, transcript variant X4
uncharacterized LOC123627673, transcript variant X4
uncharacterized LOC123627673, transcript variant X3
uncharacterized LOC123627673, transcript variant X2
uncharacterized LOC123627673, transcript variant X5
uncharacterized LOC123627673, transcript variant X6
uncharacterized LOC123627673, transcript variant X1
uncharacterized LOC123627673, transcript variant X7
uncharacterized LOC123627674, transcript variant X1
uncharacterized LOC123627674, transcript variant X2
pyroglutamylated RFamide peptide receptor
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: pyroglutamylated RF-amide peptide receptor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 39% coverage of the annotated genomic feature by RNAseq alignments
coiled-coil domain-containing protein 144A-like, transcript variant X7
coiled-coil domain-containing protein 144A-like, transcript variant X3
coiled-coil domain-containing protein 144A-like, transcript variant X4
coiled-coil domain-containing protein 144A-like, transcript variant X2
coiled-coil domain-containing protein 144A-like, transcript variant X5
coiled-coil domain-containing protein 144A-like isoform X3
coiled-coil domain-containing protein 144A-like isoform X7
coiled-coil domain-containing protein 144A-like isoform X4
coiled-coil domain-containing protein 144A-like isoform X2
coiled-coil domain-containing protein 144A-like isoform X5
coiled-coil domain-containing protein 144A-like, transcript variant X6
coiled-coil domain-containing protein 144A-like, transcript variant X1
coiled-coil domain-containing protein 144A-like isoform X1
coiled-coil domain-containing protein 144A-like isoform X6
ankyrin repeat domain-containing protein 26-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 86% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123627660, transcript variant X1
uncharacterized LOC123627660, transcript variant X3
uncharacterized LOC123627660, transcript variant X2
coiled-coil domain-containing protein 144A-like
uncharacterized LOC123627677, transcript variant X2
uncharacterized LOC123627677, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
pyroglutamylated RF-amide peptide receptor-like
uncharacterized LOC123627707, transcript variant X4
uncharacterized LOC123627707, transcript variant X5
uncharacterized LOC123627707, transcript variant X10
uncharacterized LOC123627707, transcript variant X7
uncharacterized LOC123627707, transcript variant X1
uncharacterized LOC123627707, transcript variant X9
uncharacterized LOC123627707, transcript variant X11
uncharacterized LOC123627707, transcript variant X12
uncharacterized LOC123627707, transcript variant X2
uncharacterized LOC123627707, transcript variant X8
uncharacterized LOC123627707, transcript variant X3
uncharacterized LOC123627707, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 ESTs, 1 Protein, and 74% coverage of the annotated genomic feature by RNAseq alignments
bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 67% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
POTE ankyrin domain family member A-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 54% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 82% coverage of the annotated genomic feature by RNAseq alignments
COORDINATES: nucleotide motif:Rfam:12.0:RF00015
putative neuroblastoma breakpoint family member 5, transcript variant X2
putative neuroblastoma breakpoint family member 5, transcript variant X1
putative neuroblastoma breakpoint family member 5 isoform X2
putative neuroblastoma breakpoint family member 5 isoform X1
putative neuroblastoma breakpoint family member 5, transcript variant X5
putative neuroblastoma breakpoint family member 5, transcript variant X3
putative neuroblastoma breakpoint family member 5, transcript variant X8
putative neuroblastoma breakpoint family member 5, transcript variant X4
putative neuroblastoma breakpoint family member 5, transcript variant X9
putative neuroblastoma breakpoint family member 5, transcript variant X7
putative neuroblastoma breakpoint family member 5, transcript variant X6
uncharacterized LOC123627706, transcript variant X3
uncharacterized LOC123627706, transcript variant X1
uncharacterized LOC123627706, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
zinc finger and BTB domain-containing protein 47-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 4 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 3% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 4 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger and BTB domain-containing protein 47-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 38% coverage of the annotated genomic feature by RNAseq alignments